2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride

C19H27Cl2N3 — CID 171297216

IUPAC2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride
SMILESCl.Cl.c1ccc2nc([C@@H](C3CCCC3)N3CCNCC3)ccc2c1
InChIInChI=1S/C19H25N3.2ClH/c1-2-7-16(6-1)19(22-13-11-20-12-14-22)18-10-9-15-5-3-4-8-17(15)21-18;;/h3-5,8-10,16,19-20H,1-2,6-7,11-14H2;2*1H/t19-;;/m1../s1
InChIKeyAXXGUOYVAGZBRN-JQDLGSOUSA-N
MW368.35 g/mol
LogP4.21
Rot. Bonds3

About 2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride

2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride (PubChem CID 171297216) has the molecular formula C19H27Cl2N3 and a molecular weight of 368.35 g/mol. Its IUPAC name is 2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride.

Molecular Properties

Compound Name2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride
PubChem CID171297216
Molecular FormulaC19H27Cl2N3
Molecular Weight368.35 g/mol
Exact Mass367.16
IUPAC Name2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride
SMILESCl.Cl.c1ccc2nc([C@@H](C3CCCC3)N3CCNCC3)ccc2c1
InChIInChI=1S/C19H25N3.2ClH/c1-2-7-16(6-1)19(22-13-11-20-12-14-22)18-10-9-15-5-3-4-8-17(15)21-18;;/h3-5,8-10,16,19-20H,1-2,6-7,11-14H2;2*1H/t19-;;/m1../s1
InChIKeyAXXGUOYVAGZBRN-JQDLGSOUSA-N
XLogP4.21
TPSA28.16 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds3
Heavy Atoms24
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500368.35
LogP ≤ 54.21
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Analyze 2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[(S)-cyclohexyl(piperazin-1-yl)methyl]quinoline;dihydrochloride
CID 171284597
2-[(S)-cyclopropyl(piperazin-1-yl)methyl]quinoline;dihydrochloride
CID 171284591
2-[(1S)-2-cyclopropyl-1-piperazin-1-ylethyl]quinoline;dihydrochloride
CID 171284607
1-[(S)-cyclopentyl(naphthalen-2-yl)methyl]piperazine;dihydrochloride
CID 171274893
1-[(S)-cyclopentyl-(6-methyl-2-pyridinyl)methyl]piperazine
CID 171280796
1-[(S)-(6-bromo-2-pyridinyl)-cyclobutylmethyl]piperazine;dihydrochloride
CID 171276415
1-[(S)-anthracen-9-yl(cyclopentyl)methyl]piperazine;dihydrochloride
CID 171272083
2-[(1S)-2,2-dimethyl-1-piperazin-1-ylpropyl]quinoline;dihydrochloride
CID 171284611
1-[(R)-cyclohexyl(naphthalen-2-yl)methyl]piperazine
CID 171287522
1-[(R)-anthracen-9-yl(cyclopentyl)methyl]piperazine
CID 171284710
2-[(1S)-1-piperazin-1-ylbutyl]quinoline;dihydrochloride
CID 171284605
1-[(S)-cyclopentyl(pyren-1-yl)methyl]piperazine;dihydrochloride
CID 171284515

Frequently Asked Questions

What is the IUPAC name of 2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride?
The IUPAC name of 2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride (CID 171297216) is 2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride.
What is the SMILES notation for 2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride?
The canonical SMILES for 2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride is Cl.Cl.c1ccc2nc([C@@H](C3CCCC3)N3CCNCC3)ccc2c1.
What is the InChIKey of 2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride?
The InChIKey is AXXGUOYVAGZBRN-JQDLGSOUSA-N. The full InChI is InChI=1S/C19H25N3.2ClH/c1-2-7-16(6-1)19(22-13-11-20-12-14-22)18-10-9-15-5-3-4-8-17(15)21-18;;/h3-5,8-10,16,19-20H,1-2,6-7,11-14H2;2*1H/t19-;;/m1../s1.
What are the key properties of 2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride?
2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride has a molecular weight of 368.35 g/mol, XLogP of 4.21, 3 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(R)-cyclopentyl(piperazin-1-yl)methyl]quinoline;dihydrochloride is sourced from PubChem (CID 171297216), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).